Search results for “Overweight obesity” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 113 patents, we discovered top 33 key players by total patent application. Société des Produits Nestlé SA, Acceleron Pharma, Inc., Eli Lilly & Co. are dominant in this area. They take 36.28% of the total patent filing.
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 17
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 16
Eli Lilly & Co.
Indiana, United States
Patent: 8
Adimab LLC
New Hampshire, United States
Patent: 8
Nestec SA
Vaud, Switzerland
Patent: 8
Amylin Pharmaceuticals, Inc.
California, United States
Patent: 6
Aegerion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
AstraZeneca Pharmaceuticals LP
Delaware, United States
Patent: 6
Harkness Pharmaceuticals, Inc.
California, United States
Patent: 6
Gmax Biopharm LLC
Zhejiang Sheng, China
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Acceleron Pharma, Inc., Adimab LLC, Nanchang University take 55.56% of patent filing during this period.
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 14
Adimab LLC
New Hampshire, United States
Patent: 6
Nanchang University
Jiangxi Sheng, China
Patent: 5
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 4
TdeltaS Ltd.
United Kingdom
Patent: 3
Amylin Pharmaceuticals, Inc.
California, United States
Patent: 2
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 2
FrieslandCampina Nederland BV
Groningen, Netherlands
Patent: 1
Universitas Diponegoro
Jawa Tengah, Indonesia
Patent: 1
Hubei Maternal and Child Health Hospital
undefined undefined
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents in last 5 years, we discover 12 new entrants. Nanchang University, TdeltaS Ltd., Novo Nordisk A/S are the most active new entrants in this area.
Nanchang University
Jiangxi Sheng, China
Patent: 5
TdeltaS Ltd.
United Kingdom
Patent: 3
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 2
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
undefined undefined
Patent: 1
FrieslandCampina Nederland BV
Groningen, Netherlands
Patent: 1
Universitas Diponegoro
Jawa Tengah, Indonesia
Patent: 1
Hubei Maternal and Child Health Hospital
undefined undefined
Patent: 1
Shanghai Huidong Industrial Co., Ltd.
Shanghai Shi, China
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Shanghai Institute of Endocrine and Metabolic Diseases
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 6 universities and scientific research institutions by total patent application. Nanchang University, Consejo Superior de Investigaciones Científicas, Tufts University are dominant in this area. They take 68.75% of the total patent filing.
Nanchang University
Jiangxi Sheng, China
Patent: 5
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 4
Tufts University
Massachusetts, United States
Patent: 2
University of Copenhagen
Hovedstaden, Denmark
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Universitas Diponegoro
Jawa Tengah, Indonesia
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: